Evaluation of subclinical atherosclerosis in obese patients with three noninvasive methods: Arterial stiffness, carotid intima-media thickness, and biomarkers of endothelial dysfunction
Archives of Endocrinology and Metabolism · 2023
DOI: 10.20945/2359-3997000000622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Endocrinology and Metabolism, 2023. Verfasst von Mustafa Can und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Muş State Hospital, Muş, Turkey, can1120can@gmail.com. Hauptthemen laut MEDLINE: Vascular Stiffness, Atherosclerosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
In this study, we aimed to evaluate subclinical atherosclerosis in patients with obesity who had cardiovascular disease risk indicators such as arterial stiffness, which is evaluated using pulse wave velocity (PWV), carotid intima-media thickness (CIMT), and biomarkers of endothelial dysfunction such as endocan, ADAMTS97, and ADAMTS9. Subjects and methods: Sixty obese subjects, including 23 subjects with body mass index (BMI) ≥ 40, 37 subjects with BMI ≥ 30 but < 40, and 60 age-and sex-matched control subjects, were included in our study. Serum endocan, ADAMTS97, and ADAMTS9 levels as well as PWV and CIMT measurements of the subjects in the obese and control groups were performed.
Results
In the obesity group, PWV levels were significantly higher than they were in the control group and endocan levels were significantly lower than they were in the control group. When we compared the obese group with BMI ≥ 40 and the control group, the BMI ≥ 40 group had significantly higher PWV and CIMT levels than the control group had, whereas endocan, ADAMTS7, and ADAMTS9 levels were similar to those of the control group. When we compared the obese group with BMI ≥ 30 < 40 to the control group, endocan levels were lower in the group with BMI ≥ 30 < 40, and PWV and CIMT levels were similar to the control group.
Conclusions
We found that arterial stiffness and CIMT increased in obese patients with BMI ≥ 40 and that increased arterial stiffness was associated with age, systolic blood pressure, and HBA1C. In addition, we found that the endocan levels were lower in obese patients than they were in nonobese control individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Muş State Hospital, Muş, Turkey, can1120can@gmail.com.
- Department of Endocrinology and Metabolism, Tokat State Hospital, Tokat, Turkey.
- Department of Endocrinology and Metabolism, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
- Department of Biochemistry, Faculty of Medicine, Selçuk University, Konya, Turkey.
- Department of Nephrology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Zitieren
APA
Can, M., Kocabas, M., Yarar, Z., Burgucu, H. Ç., Karaköse, M., Yerlikaya, F. H., Türkmen, K., Kulaksızoğlu, M., & Karakurt, F. (2023). Evaluation of subclinical atherosclerosis in obese patients with three noninvasive methods: Arterial stiffness, carotid intima-media thickness, and biomarkers of endothelial dysfunction. Archives of Endocrinology and Metabolism. https://doi.org/10.20945/2359-3997000000622
Vancouver
Can M, Kocabas M, Yarar Z, Burgucu HÇ, Karaköse M, Yerlikaya FH, et al. Evaluation of subclinical atherosclerosis in obese patients with three noninvasive methods: Arterial stiffness, carotid intima-media thickness, and biomarkers of endothelial dysfunction. Archives of Endocrinology and Metabolism. 2023. doi:10.20945/2359-3997000000622
BibTeX
@article{Can2023,
author = {Can, Mustafa and Kocabas, Muhammet and Yarar, Zeliha and Burgucu, Hatice Çalışkan and Karaköse, Melia and Yerlikaya, Fatma Hümeyra and Türkmen, Kültigin and Kulaksızoğlu, Mustafa and Karakurt, Feridun},
title = {Evaluation of subclinical atherosclerosis in obese patients with three noninvasive methods: Arterial stiffness, carotid intima-media thickness, and biomarkers of endothelial dysfunction},
journal = {Archives of Endocrinology and Metabolism},
year = {2023},
doi = {10.20945/2359-3997000000622}
}
EUVIMED